A member of the American Chemical Society, Evan August Weitz is a former research specialist at Pierre Group within the University of Minnesota. Evan August Weitz has made analytic probes using wet chemistry and column chromatography, and is also a co-author of several articles in scientific journals, including "A Magnetoplasmonic Agent for Copper(I) with Dual Response by MRI and Dark Field Microscopy."
Copper has been linked to neurological disorders such as Parkinson's disease and Alzheimer's disease when the metal is excess within the body. This may result in binding of the copper at irregular sites, and reactions that produce chemicals containing oxygen that are harmful and can cause stress to cells. To develop a therapy for these copper-induced disorders, researchers are investigating the role the chemistry of the excess copper plays in the pathology of such disorders. For example, in vivo (inside test-tube) studies of defective tissues from animal models of Alzheimer's disease can be useful.
0 Comments
Leave a Reply. |
AuthorEvan A. Weitz - Chemist and Electronics Tech in Greater Minneapolis. Archives
October 2019
Categories |